Surveillance analysis reports mortality risks linked to influenza antiviral therapy timing in adults hospitalized with pneumonia, highlighting uncharacterized severe clinical outcomes.
Pneumonia is common in adults hospitalized with laboratory-confirmed influenza, but the association between timeliness of influenza antiviral treatment and severe clinical outcomes in patients with influenza-associated pneumonia is not well characterized.
No takes yet. Share an insight, caveat, or question.
Tenforde et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: